Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal

Grünenthal Group Canada Europe Ontario New Jersey Germany

| Instagram: grunenthal

About Apotex and Searchlight Pharma

Apotex is a Canadian-based global health company. We improve everyday access to affordable, innovative medicines and health products for millions of people around the world, with a broad portfolio of generic, biosimilar, and innovative branded pharmaceuticals, and consumer health products. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico, and India, we are the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions.

Searchlight Pharma, the specialty pharma division of Apotex, executes best-in-class search, acquisition, and focused development of innovative and unique specialty healthcare products, with a core of its promoted products focused on women's health, dermatology, allergy, pain management and hospital specialty markets.

Learn more about us at www.apotex.com and at www.searchlightpharma.com.

Media Contacts

Grünenthal

Florian Dieckmann
Head Global Corporate Affairs

Phone: [phone]

[e-mail]

Apotex
Media, [e-mail]

 

View original content:https://www.prnewswire.co.uk/news-releases/apotex-licenses-exclusive-canadian-rights-to-qutenza-from-grunenthal-302383526.html